🔎 Trials Near Me

Почетна › Аутоимуне болести › Њујорк

Kliničke studije za Аутоимуне болести u državi Њујорк

24 studija za Аутоимуне болести traži učesnike na lokacijama u državi Њујорк.

Gradovi u državi Њујорк

Zvanični tekst studije (na engleskom)

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1036, New York
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07039916

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • Hospital for Special Surgery - Accepting Adult and Juvenile Patients, New York
  • Memorial Sloan Kettering Cancer Center - Accepting Adult and Juvenile Patients, New York
  • Children's Hospital at Montefiore - Accepting Young Adult and Juvenile Patients, The Bronx
Тражи се учесникФаза 2/3
Узраст од 6 до 75 · Оба пола · Ажурирано 13. 11. 2026. · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

  • Northwell Health: Division of Rheumatology and Allergy-Clinical Immunology, Great Neck
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07103746

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  • St Lawrence Health System, Potsdam
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07621809

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06722235

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Icahn School of Medicine at Mount Sinai, New York
Тражи се учесникФаза 1
Узраст од 18 до 74 · Оба пола · Ажурирано 2. 11. 2026. · NCT07085104

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06948318

Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases

  • Columbia University Irving Medical Center, New York
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06626919

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

  • NY Cancer and Blood Specialists, Shirley
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 22. 10. 2026. · NCT07059000

Daratumumab in Primary Antiphospholipid Syndrome

  • Northwell Health, Great Neck
  • NYU Langone, New York
  • Hospital for Special Surgery, New York
  • и још 1
Тражи се учесникФаза 1/2
Узраст од 18 до 65 · Оба пола · Ажурирано 21. 10. 2026. · NCT05671757

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

  • Columbia University, New York
  • University of Rochester Medical Center, Rochester
Тражи се учесникФаза 1/2
Узраст од 18 до 70 · Оба пола · Ажурирано 19. 10. 2026. · NCT06359041

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Columbia University Irving Medical Center, New York
  • University of Rochester, Rochester
Тражи се учесникФаза 2/3
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 10. 2026. · NCT06328777

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

  • Columbia University, New York
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 15. 10. 2026. · NCT04422912

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • University of Rochester, Rochester
Тражи се учесникФаза 1/2
Узраст од 12 до 65 · Оба пола · Ажурирано 6. 10. 2026. · NCT06121297

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

  • New York Medical College, Hawthorne
  • NorthWell, New Hyde Park
Тражи се учесникФаза 2
Узраст од 16 до 70 · Оба пола · Ажурирано 17. 9. 2026. · NCT07328581

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 9. 2026. · NCT06572384

Abatacept for the Treatment of Giant Cell Arteritis

  • Hospital for Special Surgery, New York
Тражи се учесникФаза 3
Узраст 50 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT04474847

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  • NY Nephrology, Clifton Park
  • Icahn School of Medicine at Mount Sinai, New York
Тражи се учесникФаза 3
Узраст од 18 до 100 · Оба пола · Ажурирано 17. 8. 2026. · NCT06858319

Autoimmune and Autoinflammatory Genetics Study

  • NYC H+H/Bellevue, New York
  • NYU Langone Health, New York
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
1 Month · Оба пола · Ажурирано 8. 7. 2026. · NCT06004349

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Roswell Park Cancer Institute, Buffalo
  • North Shore University Hospital, Lake Sucess
  • Cohen Children's Medical Center of New York, New Hyde
  • и још 9
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • Montefiore Medical Center, New York
Тражи се учесникФаза 1
Узраст од 12 до 70 · Оба пола · Ажурирано 22. 5. 2026. · NCT06308978

Biologics And Clinical Immunology Cohort at Sinai

  • Mount Sinai, New York
Тражи се учесникОпсервациона студија
Узраст 12 и старији · Оба пола · Ажурирано 17. 2. 2026. · NCT04784364

Allergy and Immunology Natural History Study

  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
До 99 година · Оба пола · Ажурирано 4. 2. 2026. · NCT05584488

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.